Extending HIV Drug Resistance Testing to Low Levels of Plasma Viremia

被引：9
|
作者：
Richman, Douglas D. [1 ,2 ]
机构：
[1] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA
[2] Univ Calif San Diego, Ctr AIDS Res, La Jolla, CA 92093 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 58卷 / 08期
关键词：
HIV; antiretroviral therapy; drug resistance; RESOURCE-LIMITED SETTINGS; SOCIETY-USA PANEL; ANTIRETROVIRAL TREATMENT; THERAPY; RECOMMENDATIONS; INFECTION; EMERGENCE; TRIAL;
D O I：
10.1093/cid/ciu025
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1174 / 1175
页数：2
相关论文
共 50 条
  • [1] Efficacy of genotypic drug resistance testing in patients with low-level plasma HIV-1 viremia
    Parczewski, Milosz
    Leszczyszyn-Pynka, Magdalena
    Witak-Jedra, Magdalena
    Maciejewska, Katarzyna
    Urbanska, Anna
    [J]. HIV & AIDS REVIEW, 2015, 14 (03): : 80 - 83
  • [2] A Concentration Method for HIV Drug Resistance Testing in Low-Level Viremia Samples
    Li, Qun
    Yu, Fengting
    Song, Chuan
    Zhao, Hongxin
    Yan, Liting
    Xiao, Qing
    Lao, Xiaojie
    Yang, Siyuan
    Tang, Yunxia
    Xiao, Jiang
    Zhang, Fujie
    [J]. BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [3] A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples
    Gupta, Shivani
    Taylor, Tracy
    Patterson, Aileen
    Liang, Binhua
    Bullard, Jared
    Sandstrom, Paul
    Van Domselaar, Gary
    Ji, Hezhao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [4] Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels
    Santoro, Maria Mercedes
    Fabeni, Lavinia
    Armenia, Daniele
    Alteri, Claudia
    Di Pinto, Domenico
    Forbici, Federica
    Bertoli, Ada
    Di Carlo, Domenico
    Gori, Caterina
    Carta, Stefania
    Fedele, Valentina
    D'Arrigo, Roberta
    Berno, Giulia
    Ammassari, Adriana
    Pinnetti, Carmela
    Nicastri, Emanuele
    Latini, Alessandra
    Tommasi, Chiara
    Boumis, Evangelo
    Petrosillo, Nicola
    D'Offizi, Gianpiero
    Andreoni, Massimo
    Ceccherini-Silberstein, Francesca
    Antinori, Andrea
    Perno, Carlo Federico
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (08) : 1156 - 1164
  • [5] Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels
    Geretti, A. M.
    Phillips, A.
    Kaye, S.
    Booth, C.
    Garcia, A.
    Mackie, N.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A156 - A156
  • [6] Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viremia
    Geretti, A. M.
    Phillips, A. N.
    Kaye, S.
    Booth, C.
    Mackie, N. E.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (04) : A60 - A60
  • [7] Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia
    Sirvent, JLG
    Socas, MMA
    Calzadilla, CH
    Lirola, AML
    Valls, MRA
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 111 - 113
  • [8] Going beyond guidelines: HIV-1 drug resistance testing at low-level viremia, a South African experience
    Bangalee, A.
    Steegen, K.
    Carmona, S.
    Hans, L.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 84 - 84
  • [9] HIV drug resistance testing
    Bartlett, JG
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (05) : 223 - 223
  • [10] Antiretroviral Drug Resistance in HIV-1-Infected Patients with Low-Level Viremia
    Mackie, Nicola E.
    Phillips, Andrew N.
    Kaye, Steve
    Booth, Clare
    Geretti, Anna-Maria
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (09): : 1303 - 1307
12345